Evidence map›Paper›PMID 41256364›Full record

ArticlebioRxiv : the preprint server for biology2025

Programming human cell type-specific gene expression via an atlas of AI-designed enhancers.

Sebastian M Castillo-Hair, Christopher H Yin, Leah VandenBosch, Timothy J Cherry, Wouter Meuleman, Georg Seelig

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sebastian M Castillo-HairDepartment of Electrical & Computer Engineering, University of Washington, Seattle, WA.ORCID 0000-0002-2384-3129
Christopher H YinDepartment of Electrical & Computer Engineering, University of Washington, Seattle, WA.
Leah VandenBoschCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Timothy J CherryCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Wouter MeulemanAltius Institute for Biomedical Sciences, Seattle, WA.
Georg SeeligDepartment of Electrical & Computer Engineering, University of Washington, Seattle, WA.

Funding

Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and DiseaseR01EY028584 · NEI · SEATTLE CHILDREN'S HOSPITAL · PI CHERRY, TIMOTHY JOEL · 2019 to 2025
$4.2M
Optimizing Models of Non-Coding Genetic Risk in Age-Related Macular DegenerationR01EY033364 · NEI · SEATTLE CHILDREN'S HOSPITAL · PI TIMOTHY JOEL CHERRY · 2022 to 2026
$2.5M
Elucidation of the organizing principles of the regulatory genome through large-scale data integrationR35HG011317 · NHGRI · ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES · PI MEULEMAN, WOUTER · 2020 to 2024
$1.8M
Engineering cell type-specific splicing regulationR01GM149631 · NIGMS · UNIVERSITY OF WASHINGTON · PI Georg Seelig · 2023 to 2026
$1.5M
Sequence optimization for mRNA cancer therapyR33CA286947 · NCI · UNIVERSITY OF WASHINGTON · PI Georg Seelig · 2025 to 2026
$760k
Integrating the impacts of genetic variation with massively parallel mRNA and protein barcodingR56HG013312 · NHGRI · UNIVERSITY OF WASHINGTON · PI NIVALA, JEFFREY MATTHEW, SEELIG, GEORG · 2024 to 2024
$637k
NCI NIH HHS R33 CA286947NEI NIH HHS R01 EY028584NEI NIH HHS R01 EY033364NHGRI NIH HHS R35 HG011317NHGRI NIH HHS R56 HG013312NIGMS NIH HHS R01 GM149631
6 · The paper itself

Abstract

Differentially active enhancers are key drivers of cell type specific gene expression. Active enhancers are found in open chromatin, which can be mapped at genome scale across tissue and cell types. Though incompletely understood, the relationship between chromatin accessibility and enhancer activity has been exploited to identify, model, and even design functional enhancers for selected cell types, but to what extent this design strategy can generalize across human cell and tissue types remains unclear. Here, we trained deep neural networks on a large corpus of chromatin accessibility data from hundreds of human biosamples. We used these models to generate an atlas of tens of thousands of synthetic enhancers, targeting hundreds of cell lines, tissues, and differentiation states, aiming to maximize accessibility in target samples and minimize it in all off-target ones. Experimental testing of thousands of designs in a representative subset of ten human cell types and in mouse retina demonstrated their function as specific enhancers, not only in the case of one-versus-all objectives but also when targeting two or three cell types. An explainable AI analysis, enabled by our large-scale enhancer measurements, allowed us to identify similarities and differences between the sequence grammar underlying accessibility and enhancer activity. Our results show that model-guided design of enhancers can help us decipher the cis-regulatory code governing cell type specificity and generate novel tools for selective targeting of human cell states.

Identifiers

PMID41256364
PMCPMC12622110

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.